These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 2991779

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Investigations of the mechanism of the positive inotropic action of BDF 9148: comparison with DPI 201-106 and the enantiomers.
    Raap A, Armah B, Mest HJ, Stenzel W, Schloos J, Blechacz W.
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):164-73. PubMed ID: 9057064
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T, Ohhara H, Tsunoda H, Kuroki J, Shoji T.
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [Abstract] [Full Text] [Related]

  • 11. Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations.
    Pérez O, Gay P, Franqueza L, Carrón R, Valenzuela C, Delpón E, Tamargo J.
    Br J Pharmacol; 1995 Jul; 115(5):787-94. PubMed ID: 8548178
    [Abstract] [Full Text] [Related]

  • 12. Reversal of the cardiotonic and action-potential prolonging effects of DPI 201-106 by BDF 8784, a methyl-indol derivative.
    Armah BI, Pfeifer T, Ravens U.
    Br J Pharmacol; 1989 Apr; 96(4):807-16. PubMed ID: 2568142
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic and electrophysiological effects of a novel positive inotropic drug, OPC-8212, in normal and "failing" guinea pig heart preparations.
    Grupp G, Grupp IL, Kojima M, Sperelakis N, Tsuchiya Y, Hosokawa T, Schwartz A.
    J Cardiovasc Pharmacol; 1986 Apr; 8(2):428-40. PubMed ID: 2422485
    [Abstract] [Full Text] [Related]

  • 14. Positive inotropic and electrophysiological effects of APP 201-533 can be explained by an increase of cardiac cyclic AMP.
    Scholtysik G, Honerjäger P, Markstein R, Bormann G.
    J Cardiovasc Pharmacol; 1985 Apr; 7(3):597-603. PubMed ID: 2410695
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanisms of positive inotropic effects and delayed relaxation produced by DPI 201-106 in mammalian working myocardium: effects on intracellular calcium handling.
    Kihara Y, Gwathmey JK, Grossman W, Morgan JP.
    Br J Pharmacol; 1989 Apr; 96(4):927-39. PubMed ID: 2743084
    [Abstract] [Full Text] [Related]

  • 19. In vitro investigations on a new positive inotropic and vasodilating agent (BM 14.478) that increases myocardial cyclic AMP content and myofibrillar calcium sensitivity.
    Müller-Beckmann B, Freund P, Honerjäger P, Kling L, Rüegg JC.
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):8-16. PubMed ID: 2450261
    [Abstract] [Full Text] [Related]

  • 20. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D, von der Leyen H, Meyer W, Schmidt-Schumacher C, Scholz H.
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.